AstraZeneca Investors - Financial results 2002

Go to navigation
Go to content

30 January 2003

Fourth quarter and full year results 2002

Narrative - (PDF 179 kb)

Figures - (PDF 187 kb)

Quarterly sales adjusted for reclassification of cash discounts - (PDF 87 kb)

R&D pipeline table as presented 3rd December 2002 - (PDF 107 kb)

Presentation - (PDF 337 kb)

23 October 2002

Third quarter and nine months results 2002

Narrative - (PDF 52 kb)

Figures - (PDF 38 kb)

25 July 2002

Second quarter and half year results 2002

Narrative - (PDF 57 kb)

Figures - (PDF 51 kb)

R&D pipeline table - (PDF 42 kb)

25 April 2002

First quarter 2002

Narrative - (PDF 53 kb)

Figures - (PDF 31 kb)

Not signed in

Page tools

Share price

London: 26.95 GBP
New York: 44.82 USD
Stockholm: 310.10 SEK

At 21-Nov-2009 10:43 GMT

Detailed share price

Stock symbol - AZN

On LSE, NYSE and OMX

Introduction to AstraZeneca

Our responsibility

We continue to communicate openly on a range of issues, including:

Contact us

Stay in touch

Subscribe via RSS

This website is intended for people seeking information on the AstraZeneca International business. If you are in the US you should visit AstraZeneca US.

We also have national business sites which can be found under our list of AstraZeneca websites.

We also have specific national and international websites designed for patients and healthcare professionals. If you have a question you can contact us.